Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b59401c9dffac1d3e6c01e5e6cbb6cd9 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-48 |
filingDate |
2018-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acb4089bf02d0b6770709d3e0086e92c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_720f6fdec068e92b837cb75542584013 |
publicationDate |
2019-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10472351-B2 |
titleOfInvention |
Small molecule agonists and antagonists of NR2F6 activity in animals |
abstract |
The present technology is directed to modulators of nuclear receptor activity, specifically to the modulation of NR2F6 activity and NR2F6 utilizing compounds, and the immune modulation and modulation of cancer stem cell activity through administration of compounds described herein to animals. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11377442-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018346456-A1 |
priorityDate |
2016-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |